Back to Search Start Over

Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center.

Authors :
Porcaro AB
Bianchi A
Gallina S
Panunzio A
Serafin E
Mazzucato G
Orlando R
Montanaro F
Patuzzo GM
Baielli A
Artoni F
Ditonno F
Vidiri S
D'Aietti D
Migliorini F
Rizzetto R
Veccia A
Gozzo A
Brunelli M
Tafuri A
Cerruto MA
Antonelli A
Source :
Aging clinical and experimental research [Aging Clin Exp Res] 2023 Sep; Vol. 35 (9), pp. 1881-1889. Date of Electronic Publication: 2023 Jun 19.
Publication Year :
2023

Abstract

Objectives: This study aimed to assess more clinical and pathological factors associated with prostate cancer (PCa) progression in high-risk PCa patients treated primarily with robot-assisted radical prostatectomy (RARP) and extended pelvic lymph node dissection (ePLND) in a tertiary referral center.<br />Materials and Methods: In a period ranging from January 2013 to October 2020, RARP and ePLND were performed on 180 high-risk patients at Azienda Ospedaliera Universitaria Integrata of Verona (Italy). PCa progression was defined as biochemical recurrence/persistence and/or local recurrence and/or distant metastases. Statistical methods evaluated study endpoints, including Cox's proportional hazards, Kaplan-Meyer survival curves, and binomial logistic regression models.<br />Results: The median age of included patients was 66.5 [62-71] years. Disease progression occurred in 55 patients (30.6%), who were more likely to have advanced age, palpable tumors, and unfavorable pathologic features, including high tumor grade, stage, and pelvic lymph node invasion (PLNI). On multivariate analysis, PCa progression was predicted by advanced age (≥ 70 years) (HR = 2.183; 95% CI = 1.089-4377, p = 0.028), palpable tumors (HR = 3.113; 95% CI = 1.499-6.465), p = 0.002), and PLNI (HR = 2.945; 95% CI = 1.441-6.018, p = 0.003), which were associated with clinical standard factors defining high-risk PCa. Age had a negative prognostic impact on elderly patients, who were less likely to have palpable tumors but more likely to have high-grade tumors.<br />Conclusions: High-risk PCa progression was independently predicted by advanced age, palpable tumors, and PLNI, which is associated with standard clinical prognostic factors. Consequently, with increasing age, the prognosis is worse in elderly patients, who represent an unfavorable age group that needs extensive counseling for appropriate and personalized management decisions.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
1720-8319
Volume :
35
Issue :
9
Database :
MEDLINE
Journal :
Aging clinical and experimental research
Publication Type :
Academic Journal
Accession number :
37337076
Full Text :
https://doi.org/10.1007/s40520-023-02466-z